About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03148587

Medical Abortion Self-Confirmation (MASC)

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, with...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Stanford University

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Gestational age of less than or equal to 63 days
•English speaking
•Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
•In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form

Exclusion Criteria

•Allergy to mifepristone and/or misoprostol
•Non-english speaking
•Inability to access internet

Related studies

Success Rates of Expectant vs. Medical Management for Retained Products After First-Trimester Abortion: Randomized Controlled Trial

NCT07534982 · Retained Product of Conception After First Trimester Medical Abortion

Active Not Recruiting

Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :

NCT06708208 · Pregnancy, Violence Against Women (VAW), and more

Not Yet Recruiting

Long Term Impact of Induced Abortion

NCT06795334 · Non-medical Abortion Surgery

Second Trimester Medical Abortion

NCT04160221 · Medical Abortion, Complete or Unspecified, Without Complication

TERMINATEDPhase 4

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

NCT05119439 · Medical Abortion

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 7, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment88

Start dateMay 2017

Last updatedJun 7, 2019

Condition

Medical Abortion

Locations shown

Stanford Health Care

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 7, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions